Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, October 18, 2023

Global Real-Time PCR and Digital PCR Market is Anticipated to Grow at a CAGR of 7.2% during 2024 to 2030

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Some of the key questions answered in this exclusive report are:

Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3.  Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6.  What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Market Segmentation:

In this market, clinical, research, and forensic are the major segments of real-time PCR and digital PCR market by application. Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Within this market, hospital and diagnostic center will remain the largest segment due to increasing need for qPCR and dPCR in this facility to obtain rapid and effective disease detection and treatment.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region. 

F. Hoffmann La Roche, Takara Bio, Becton and Dickinson, Agilent Technologies, Merck KGaA, Qiagen, Abbott Laboratories, Thermo Fisher Scientific, Danaher, and Bio Rad Laboratories are the major suppliers in the real-time PCR and digital PCR market.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. 972.636.5056

Related Reports

1. Pharmaceutical Contract Manufacturing Market

 

2. Medical Battery Market

 

3. Stent Market

 

4. Wheelchair Market 


5. 3D Printing Medical Device Market


6. Medical Device Market

 

7. Diagnostic Imaging Market

 

8.  Medical Lifting Sling Market

 

9.  Liquid Biopsy Market

 

10.  Stretcher Market

No comments:

Post a Comment